NO781050L - Nye cephalosporiner, samt fremgangsmaate ved fremstilling av disse - Google Patents
Nye cephalosporiner, samt fremgangsmaate ved fremstilling av disseInfo
- Publication number
- NO781050L NO781050L NO781050A NO781050A NO781050L NO 781050 L NO781050 L NO 781050L NO 781050 A NO781050 A NO 781050A NO 781050 A NO781050 A NO 781050A NO 781050 L NO781050 L NO 781050L
- Authority
- NO
- Norway
- Prior art keywords
- group
- formula
- hydrogen
- compound
- amino
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 13
- 229940124587 cephalosporin Drugs 0.000 title claims description 9
- 229930186147 Cephalosporin Natural products 0.000 title claims description 6
- 238000002360 preparation method Methods 0.000 title claims description 3
- HOKIDJSKDBPKTQ-GLXFQSAKSA-N cephalosporin C Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims description 16
- -1 cyanomethyl Chemical group 0.000 claims description 12
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- 239000001257 hydrogen Substances 0.000 claims description 11
- 150000002431 hydrogen Chemical group 0.000 claims description 8
- 150000001780 cephalosporins Chemical class 0.000 claims description 5
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 150000002367 halogens Chemical group 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- IXZDIALLLMRYOU-UHFFFAOYSA-N tert-butyl hypochlorite Chemical compound CC(C)(C)OCl IXZDIALLLMRYOU-UHFFFAOYSA-N 0.000 claims description 3
- 125000003282 alkyl amino group Chemical group 0.000 claims description 2
- 125000004414 alkyl thio group Chemical group 0.000 claims description 2
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- 125000005518 carboxamido group Chemical group 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- JILPJDVXYVTZDQ-UHFFFAOYSA-N lithium methoxide Chemical compound [Li+].[O-]C JILPJDVXYVTZDQ-UHFFFAOYSA-N 0.000 claims description 2
- HRDXJKGNWSUIBT-UHFFFAOYSA-N methoxybenzene Chemical group [CH2]OC1=CC=CC=C1 HRDXJKGNWSUIBT-UHFFFAOYSA-N 0.000 claims description 2
- 125000005633 phthalidyl group Chemical group 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 claims description 2
- 125000005301 thienylmethyl group Chemical group [H]C1=C([H])C([H])=C(S1)C([H])([H])* 0.000 claims description 2
- 125000006000 trichloroethyl group Chemical group 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 238000002955 isolation Methods 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 2
- CKNQOKQJFOLEAP-UHFFFAOYSA-N (hydroxyamino)oxysulfonylformic acid Chemical group ONOS(=O)(=O)C(=O)O CKNQOKQJFOLEAP-UHFFFAOYSA-N 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- 235000013312 flour Nutrition 0.000 claims 1
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 claims 1
- 125000005031 thiocyano group Chemical group S(C#N)* 0.000 claims 1
- 125000003396 thiol group Chemical class [H]S* 0.000 claims 1
- 230000007306 turnover Effects 0.000 claims 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 125000001544 thienyl group Chemical group 0.000 description 6
- 101150041968 CDC13 gene Proteins 0.000 description 5
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- HKAVADYDPYUPRD-UHFFFAOYSA-N 1h-pyrazine-2-thione Chemical class SC1=CN=CC=N1 HKAVADYDPYUPRD-UHFFFAOYSA-N 0.000 description 2
- 241000588697 Enterobacter cloacae Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- AUENQRMLHKNCRE-VLHGOJDXSA-N (6R)-4-acetamido-4-benzhydryl-3-[(3-methoxypyrazin-2-yl)sulfanylmethyl]-8-oxo-7-thiophen-2-yl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound CC(=O)NC1(C(=C(N2[C@H](S1)C(C2=O)C3=CC=CS3)C(=O)O)CSC4=NC=CN=C4OC)C(C5=CC=CC=C5)C6=CC=CC=C6 AUENQRMLHKNCRE-VLHGOJDXSA-N 0.000 description 1
- JHWOBKLTTLRWML-YYGLIYBVSA-N (6R)-4-acetamido-4-benzhydryl-8-oxo-3-(pyrazin-2-ylsulfanylmethyl)-7-thiophen-2-yl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound CC(=O)NC1(C(=C(N2[C@H](S1)C(C2=O)C3=CC=CS3)C(=O)O)CSC4=NC=CN=C4)C(C5=CC=CC=C5)C6=CC=CC=C6 JHWOBKLTTLRWML-YYGLIYBVSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- FADWHMWTUOKTMV-UHFFFAOYSA-N 6-methoxy-1h-pyrazine-2-thione Chemical compound COC1=CN=CC(S)=N1 FADWHMWTUOKTMV-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- PKOMXLRKGNITKG-UHFFFAOYSA-L calcium;hydroxy(methyl)arsinate Chemical compound [Ca+2].C[As](O)([O-])=O.C[As](O)([O-])=O PKOMXLRKGNITKG-UHFFFAOYSA-L 0.000 description 1
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 1
- 229960001139 cefazolin Drugs 0.000 description 1
- HOKIDJSKDBPKTQ-GLXFQSAKSA-M cephalosporin C(1-) Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H]([NH3+])C([O-])=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-M 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- NPOMSUOUAZCMBL-UHFFFAOYSA-N dichloromethane;ethoxyethane Chemical compound ClCCl.CCOCC NPOMSUOUAZCMBL-UHFFFAOYSA-N 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical compound C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 238000006198 methoxylation reaction Methods 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical compound [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 125000006502 nitrobenzyl group Chemical group 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/57—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with a further substituent in position 7, e.g. cephamycines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB12819/77A GB1579533A (en) | 1977-03-26 | 1977-03-26 | Cephalosporins and their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO781050L true NO781050L (no) | 1978-09-27 |
Family
ID=10011720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO781050A NO781050L (no) | 1977-03-26 | 1978-03-22 | Nye cephalosporiner, samt fremgangsmaate ved fremstilling av disse |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4206211A (el) |
| JP (1) | JPS53121790A (el) |
| AT (1) | AT359189B (el) |
| AU (1) | AU514878B2 (el) |
| BE (1) | BE865175A (el) |
| CA (1) | CA1098118A (el) |
| CH (1) | CH637966A5 (el) |
| CS (1) | CS202594B2 (el) |
| DE (1) | DE2812626A1 (el) |
| DK (1) | DK127878A (el) |
| FR (1) | FR2384784A1 (el) |
| GB (1) | GB1579533A (el) |
| GR (1) | GR62540B (el) |
| IE (1) | IE46712B1 (el) |
| IL (1) | IL54203A (el) |
| NL (1) | NL7803282A (el) |
| NO (1) | NO781050L (el) |
| NZ (1) | NZ186619A (el) |
| SE (1) | SE7803388L (el) |
| SU (1) | SU882413A3 (el) |
| YU (1) | YU60978A (el) |
| ZA (1) | ZA781283B (el) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3821207A (en) * | 1971-06-21 | 1974-06-28 | Smithkline Corp | 7-heterocyclic substituted cephalosporins |
| BE787635A (fr) * | 1971-08-20 | 1973-02-19 | Takeda Chemical Industries Ltd | Cephalosporines |
| US3984403A (en) * | 1972-06-30 | 1976-10-05 | Takeda Chemical Industries, Ltd. | Arginine and lysine salts of acid cephalosporins |
| GB1449420A (en) * | 1973-11-26 | 1976-09-15 | Sankyo Co | 7alpha-methoxycephalosporing derivatives |
| US4059578A (en) * | 1974-09-09 | 1977-11-22 | Smithkline Corporation | 7-Substituted mercaptoacetamido cephamycins |
| DK154939C (da) * | 1974-12-19 | 1989-06-12 | Takeda Chemical Industries Ltd | Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf |
| DE2539214C2 (de) * | 1975-09-03 | 1984-03-29 | E.R. Squibb & Sons, Inc., 08540 Princeton, N.J. | 7-Methoxythienyl-ureido-cephalosporin und dieses enthaltendes Arzneimittel |
| US4128723A (en) * | 1977-02-02 | 1978-12-05 | E. R. Squibb & Sons, Inc. | Cyanoalkylureido cephalosporins |
-
1977
- 1977-03-26 GB GB12819/77A patent/GB1579533A/en not_active Expired
-
1978
- 1978-03-03 NZ NZ186619A patent/NZ186619A/xx unknown
- 1978-03-06 ZA ZA00781283A patent/ZA781283B/xx unknown
- 1978-03-06 IL IL54203A patent/IL54203A/xx unknown
- 1978-03-06 CH CH237878A patent/CH637966A5/it not_active IP Right Cessation
- 1978-03-10 US US05/885,126 patent/US4206211A/en not_active Expired - Lifetime
- 1978-03-14 GR GR55706A patent/GR62540B/el unknown
- 1978-03-17 AU AU34244/78A patent/AU514878B2/en not_active Expired
- 1978-03-21 CS CS781786A patent/CS202594B2/cs unknown
- 1978-03-21 DK DK127878A patent/DK127878A/da not_active Application Discontinuation
- 1978-03-21 IE IE566/78A patent/IE46712B1/en unknown
- 1978-03-22 DE DE19782812626 patent/DE2812626A1/de not_active Ceased
- 1978-03-22 NO NO781050A patent/NO781050L/no unknown
- 1978-03-22 FR FR7808271A patent/FR2384784A1/fr active Granted
- 1978-03-22 BE BE186166A patent/BE865175A/xx not_active IP Right Cessation
- 1978-03-23 SE SE7803388A patent/SE7803388L/xx unknown
- 1978-03-23 CA CA299,694A patent/CA1098118A/en not_active Expired
- 1978-03-24 AT AT213078A patent/AT359189B/de not_active IP Right Cessation
- 1978-03-24 JP JP3399878A patent/JPS53121790A/ja active Pending
- 1978-03-24 SU SU782594352A patent/SU882413A3/ru active
- 1978-03-28 NL NL7803282A patent/NL7803282A/xx unknown
- 1978-12-28 YU YU00609/78A patent/YU60978A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1098118A (en) | 1981-03-24 |
| AT359189B (de) | 1980-10-27 |
| IL54203A (en) | 1981-05-20 |
| SU882413A3 (ru) | 1981-11-15 |
| IE46712B1 (en) | 1983-09-07 |
| GB1579533A (en) | 1980-11-19 |
| IL54203A0 (en) | 1978-06-15 |
| DE2812626A1 (de) | 1978-09-28 |
| CH637966A5 (it) | 1983-08-31 |
| NL7803282A (en) | 1978-09-28 |
| DK127878A (da) | 1978-09-27 |
| FR2384784A1 (fr) | 1978-10-20 |
| AU3424478A (en) | 1979-09-20 |
| IE780566L (en) | 1978-09-26 |
| ATA213078A (de) | 1980-03-15 |
| GR62540B (en) | 1979-05-04 |
| YU60978A (en) | 1983-01-21 |
| BE865175A (fr) | 1978-09-22 |
| JPS53121790A (en) | 1978-10-24 |
| FR2384784B1 (el) | 1982-05-28 |
| AU514878B2 (en) | 1981-03-05 |
| US4206211A (en) | 1980-06-03 |
| NZ186619A (en) | 1979-10-25 |
| CS202594B2 (en) | 1981-01-30 |
| SE7803388L (sv) | 1978-09-27 |
| ZA781283B (en) | 1979-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0005889B1 (en) | Process for the preparation of beta-lactam derivatives, the novel derivatives so obtainable and pharmaceutical compositions containing them | |
| NO159019B (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive 6beta-hydroksyalkylpenicillansyrederivater. | |
| NO173016B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-laktamderivater | |
| JPS6124396B2 (el) | ||
| CA1109859A (en) | Thiooxime cephalosporin and penicillin derivatives | |
| NO170021B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-propenylcefem-derivater | |
| NO773081L (no) | Nye bicykliske forbindelser. | |
| US4356174A (en) | Beta-lactamase inhibiting 2-beta-substituted-2-alpha-methyl-(5R)penam-3-alpha-carboxylic acid 1,1-dioxides and intermediates therefor | |
| KR840000589B1 (ko) | 6-β-치환된 페니실란산의 제조방법 | |
| US4166816A (en) | Methods and intermediates for preparing cis-4-oxoazetidine intermediates | |
| NO164598B (no) | Fremgangsmaate for fremstilling av klormetylestere av penicillansyrer. | |
| NO781050L (no) | Nye cephalosporiner, samt fremgangsmaate ved fremstilling av disse | |
| Yanagisawa et al. | Synthesis of 7α-substituted cephalosporins. V Novel oxidation procedure for syntheses of 7α-methoxycephalosporins and 6α-methoxypenicillins | |
| US3941779A (en) | Method for producing 2-(substituted thio)-3-cephem derivatives | |
| US4072674A (en) | Cis-4-oxoazetidine intermediates and methods of preparing them | |
| US4051129A (en) | Process for preparing 7-methoxycephalosporin compounds | |
| NO833415L (no) | Fremgangsmaate for fremstilling av 6-aminoalkylpenicillansyre-1,1-dioksyder | |
| KR870000313B1 (ko) | 6-(아미노메틸)페니실란산 1,1-다이옥사이드 및 이의 유도체의 제조방법 | |
| NO743991L (el) | ||
| US4257947A (en) | 3-Amino-2-hydroxy, halo or mercaptomethyl-4-oxoazetidines | |
| US4169833A (en) | Novel phosphorane intermediates for use in preparing penem antibiotics | |
| CA1102308A (en) | Carbon and oxygen analogs of cephalosporins | |
| Singh et al. | Desulfation and rearrangement of tigemonam to an isoxazolidin‐5‐one and the synthesis of the rearrangement product | |
| DK145060B (da) | Analogifremgangsmaade til fremstilling af 6-acylamino-2,2-dimethyl-3-phosphonopenam-forbindelser eller salte deraf | |
| Roets et al. | PREPARATION OF 6-EPI-AMPICILLIN AND OF 6-EPI-α-HYD ROXYBENZYLPENICI LLIN |